Omaha ABA Therapy: Comparing the Top Providers
[Sponsored] The right provider enables children to gain confidence, learn to express their needs and…
Omaha ABA Therapy: Comparing the Top Providers
[Sponsored] The right provider enables children to gain confidence, learn to express their needs and discover new ways to connect with the world around them. The post Omaha ABA Therapy: Comparing the Top Providers appeared first on MedCity News.
Reducing EMS Documentation Time Without Sacrificing Accuracy
For field providers, the goal isn’t just faster paperwork — it’s smarter, safer documentation that puts patient care first. The post Reducing EMS Documentation Time Without Sacrificing Accuracy appeared first on MedCity News.
Sticker Shock: Obamacare Customers Confront Premium Spikes as Congress Dithers
We’ve been here before: congressional Democrats and Republicans sparring over the future of the Affordable Care Act. But this time there’s an extra complication. Though it’s the middle of open enrollment, lawmakers are still debating whether to extend the subsidies that have given consumers extra help paying their health insurance premiums in recent years. The…
Vaccine Panel’s Hepatitis B Vote Signals Further Turbulence for Immunization Policy, Public Trust
When Su Wang was in medical school, she donated blood. That’s when she learned she was infected with hepatitis B, a virus that attacks the liver and can lead to cancer and death decades later. “I was 18, healthy, in college,” she said. “And suddenly I had a chronic illness I didn’t even know about.”…
How do CMS negotiated prices compare to value?
That is the question asked in a recent Health Affairs Forefront article by Peter Neumann, Josh Cohen, Sean Sullivan and Feng Xie. They compare the CMS negotiated prices for Initial Price Applicability Year (IPAY) 2027 against value-based prices (using QALYs) from the Tufts Cost-Effectiveness Analysis (CEA) Registry. The authors found that cost-effectiveness estimates varied among…
Vanderbilt CEO: Health Systems Can Fix Prior Auth Without Waiting for Payers
Health systems should take the lead in fixing the broken prior authorization process, said Jeff Balser, CEO of Vanderbilt University Medical Center, during a recent conference. He highlighted AI, better workflows and centralized support as ways to reduce delays. The post Vanderbilt CEO: Health Systems Can Fix Prior Auth Without Waiting for Payers appeared first…
MedCity Pivot Podcast: A Flexible Approach to Pharmacy Benefits Management
[Sponsored] Pharmacy benefit managers are under scrutiny for their business practices that are often blamed for contributing to the rising costs of prescription drugs in America. But one PBM is paving another way that alters the traditional operating model. The post MedCity Pivot Podcast: A Flexible Approach to Pharmacy Benefits Management appeared first on MedCity…
Let’s get moving on AI-discovered treatments
By STEVEN ZECOLA Recursion Pharmaceuticals announced results today for one its AI-discovered treatments. I was pleased to see the large, sustained reduction in polyps attributable to its treatment for Familial Adenomatous Polyposis. Recursions’ oral medication will be viewed by the traditional scientific and regulatory community as “promising”. On the other hand, I was disappointed not…
What the Health? From KFF Health News: Crunch Time for ACA Tax Credits
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Eli Lilly Drug for 3 Obesity Targets Sets New High Bar for Weight Loss in a Clinical Trial
The high dose of Eli Lilly’s retatrutide led to an average 28.7% loss in body weight measured at 68 weeks. These Phase 3 results are the first from the experimental obesity drug’s broad clinical trial program, which is on track to yield seven data readouts in the coming year. The post Eli Lilly Drug for…
